v3.25.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current assets    
Cash $ 239,604 $ 155,647
Restricted cash 71,079
Accounts receivable, net of allowance for credit losses of $9,476 and $13,400 as of June 30, 2025 and December 31, 2024, respectively 2,381 6,966
Note receivable 3,500,000
Equity investment 466,500
Inventories 184,540 212,494
Prepaid expenses and other 815,252 33,830
Interest receivable 36,888
Total current assets 1,312,856 4,412,325
Fixed assets, net    
Computer equipment, net 7,022
Goodwill 97,609,814
Total assets 98,929,692 4,412,325
Current liabilities    
Accounts payable 9,586,411 1,108,777
Accrued compensation 337,690
Accrued creator commissions 2,441,450
Settlement payable 622,839 484,735
Accrued expenses 2,502,979 596,610
Accrued expenses - related parties 309,333 309,333
Accrued sales tax 1,959,219
Deferred revenue 4,140,533 1,919
Financing arrangement, net of discount 517,021
Convertible notes payable, net of discount 392,142 432,105
Notes payable, current portion, net of discount 5,493,325
Total current liabilities 28,302,942 2,933,479
Total liabilities 28,302,942 2,933,479
Series A preferred stock, $0.001 par value – 10,000 shares authorized at June 30, 2025 and December 31, 2024; 7,013 shares issued and outstanding at June 30, 2025 and December 31, 2024, preference in liquidation of $1,344,723 and $1,597,706 at June 30, 2025 and December 31, 2024, respectively 7 9
Series B preferred stock, $0.001 par value – 50,000 shares authorized at June 30, 2025 and December 31, 2024; 39,250 shares issued and outstanding at June 30, 2025 and December 31, 2024, preference in liquidation of $5,887,500 at June 30, 2025 and December 31, 2024 39 50
Series C preferred stock, $0.001 par value – 100,000 and 0 shares authorized at June 30, 2025 and December 31, 2024, respectively; 8,550 and 0 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively; preference in liquidation of $855,000 and $0 at June 30, 2025 and December 31, 2024, respectively 9
Series D preferred stock, $0.001 par value – 750,000 and 0 shares authorized at June 30, 2025 and December 31, 2024, respectively; 0 and 0 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively; preference in liquidation of $0 and $0 at June 30, 2025 and December 31, 2024, respectively
Common stock, $0.001 par value - 100,000,000 shares authorized at June 30, 2025 and December 31, 2024; 5,108,649 shares issued and outstanding at June 30, 2025 and December 31, 2024 5,110 776
Additional Paid-In Capital 107,027,294 30,636,812
Accumulated deficit (36,405,709) (29,158,801)
Total stockholder’s equity 70,626,750 1,478,846
Total liabilities and stockholders’ equity $ 98,929,692 $ 4,412,325

Source